Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sompo Holdings is a large Japanese insurance holding company whose core businesses span domestic property and casualty insurance, overseas insurance, domestic life insurance, and nursing care. While it is not a biotech or pharmaceutical developer, it has meaningful healthcare exposure through its SOMPO Wellbeing segment, including Sompo Himawari Life and Sompo Care, which provide health-support, life insurance, and senior nursing-care services. The company positions itself around health, wellbeing, and financial protection rather than therapeutic product development. Its healthcare-related activities are service-led and insurance-led, with a focus on elderly care, health support, and integrated wellbeing offerings in Japan. For a biotech analyst, Sompo Holdings is best understood as a diversified insurer with adjacent healthcare and eldercare operations rather than a drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sompo Holdings.